demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 severe or critically
COVID-19 (hospitalized or not)
Oral antidiabetic drugs
DPP-4 inhibitor Rhee

0 studies excluded by filtering options 2